Recent Activity

Loading...

ANIP

ANI Pharmaceuticals, Inc. · NASDAQ

Performance

-6.75%

1W

-6.3%

1M

+2.86%

3M

+19.86%

6M

+11.41%

YTD

+38.04%

1Y

Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Investment Analysis Report: ANIP

Overview

ANIP is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1.22 billion. In this report, we will conduct a comprehensive analysis of ANIP's financial statements over the past three years to evaluate its financial he...

See more ...

Technical Analysis of ANIP 2024-05-10

Overview:

In analyzing the technical indicators for ANIP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
See more ...

Recent News & Updates